PATENT CLAIM ANALYSIS

Application Number: 16017713
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "426000"]

Abstract:
Disclosed herein are methods of treating venous thrombosis and vascular inflammation through administration of carbon monoxide and/or a carbon monoxide releasing molecule. Also disclosed herein are devices capable of releasing carbon monoxide for the purpose of treating microvascular, arterial and venous thromboembolism and/or inflammation.

Claim (Index 7):
The method of  claim 6 , wherein the one or more therapeutic agents comprises nitric oxide or a compound that releases nitric oxide, oxygen, an anticoagulant, an anti-inflammatory agent, a protease activated receptor (\u201cPAR\u201d) inhibitor, a thienopyridine, a lipoxygenase-derived platelet inhibitor, a cell adhesion molecule inhibitor, or combinations thereof;\n optionally wherein the compound that releases nitric oxide selected from the group consisting of SIN-1, NCX-4016, NCX-701, nitroglycerin, sodium nitroprusside, and a combination thereof; optionally wherein the anticoagulant is selected from the group consisting of a coumarin, an indandione, a factor Xa inhibitor, factor XI inhibitor, factor XII inhibitor, factor XIII inhibitor, a heparin, a thrombin inhibitor, and a combination thereof; optionally wherein the factor Xa inhibitor is fondaparinux, rivaroxaban, apixaban, edoxaban, otamixaban, letaxaban, eribaxaban, darexaban, or a combination thereof; optionally wherein the heparin is dalteparin, tinzaparin, enoxaparin, heparin, danaparoid, or a combination thereof; and optionally wherein the thrombin inhibitor is bivalirudin, dabigatran, argatroban, desirudin, lepirudin, or combinations thereof.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 94.0
- Lexical Diversity: 1.51613
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11793820', '13501278', '14253750', '15232773', '15736933']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7666231371956752
- 35 USC 102 Novelty (BERT): 0.5127782605181883
- Combined Prediction Score: 0.7412386495279265
- Mean Citation Score: 229.541116
- Max Citation Score: 244.04114
- Similarity Product: 136.83575801319478

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test